Clariane SE (FRA:KO2) Issuance of Debt: €1,253 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KO2 Clariane SE FRA:KO2
59 GF Score
Price €4.00
GF Value €2.49
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clariane SE Issuance of Debt?

Clariane SE FRA:KO2 +0.20% 59 Issuance of Debt is €1,253 Mil as of Jun. 2026. GuruFocus rates FRA:KO2 with a GF Score™ of 59/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Clariane SE's Issuance of Debt for the six months ended in Jun. 2026 was €877 Mil.

Clariane SE's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was €1,253 Mil.

Clariane SE Issuance of Debt Related Terms

Clariane SE Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Clariane SE's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Issuance of Debt Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,832.46 811.06 1,148.30 141.95 979.72

Clariane SE Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.24 95.72 603.98 375.73 877.19
FRA:KO2
59GF Score
Clariane SE FRA:KO2
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,253 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €1,253 Mil mean?
Clariane SE (FRA:KO2) has a Issuance of Debt of €1,253 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Clariane SE and its competitors.
Is Clariane SE's Issuance of Debt too high?
Clariane SE's current Issuance of Debt is €1,253 Mil. Overall, Clariane SE has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Issuance of Debt compare to HCA and THC?
Clariane SE's Issuance of Debt of €1,253 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Healthcare Providers & Services company?
A good Issuance of Debt depends on the Healthcare Providers & Services industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Clariane SE and its competitors. Clariane SE's current Issuance of Debt is €1,253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (FRA:KO2) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.00 — trading 60.8% above its estimated fair value. The current Issuance of Debt is €1,253 Mil. Clariane SE's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Clariane SE (FRA:KO2), the current Issuance of Debt is €1,253 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (FRA:KO2) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.00 is trading 60.8% above its estimated GF Value™ of €2.49. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for FRA:KO2:

  • Issuance of Debt: €1,253 Mil
  • GF Value™: €2.49 vs. price of €4.00 (60.8% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
59GF Score

Get the complete analysis for FRA:KO2

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.00
Price
€2.49
GF Value